SJS Investment Consulting’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
AIM
FWIA
DLA
ETC
SJS Investment Consulting's BMY Position: Q2 2026 in Review
SJS Investment Consulting increased its Bristol-Myers Squibb (BMY) stake by 4.1% in Q2 2026, buying an estimated $6.78K and bringing the position to 2,963 shares worth $171K. The position accounts for 0.02% of the portfolio, ranked #177.
SJS Investment Consulting first reported a position in BMY in Q4 2021 and has held it in 18 quarters since. The position peaked at $173K in Q1 2026. 878 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- SJS Investment Consulting held 2,963 shares of Bristol-Myers Squibb worth $171K as of Q2 2026.
- SJS Investment Consulting bought 118 Bristol-Myers Squibb shares in Q2 2026, an estimated $6.78K.
- Bristol-Myers Squibb made up 0.02% of SJS Investment Consulting's portfolio in Q2 2026, its #177 holding.
- SJS Investment Consulting first reported a position in Bristol-Myers Squibb in Q4 2021 and has held it in 18 quarters since.
- SJS Investment Consulting's Bristol-Myers Squibb position peaked at $173K in Q1 2026.
- 878 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on SJS Investment Consulting's 13F filing for Q2 2026, filed 22 Jul 2026.